The Therapeutic Goods Administration is experiencing system issues linked to global Microsoft outages. Some services may be disrupted and we may take longer to respond to email and phone contact during this time.
Wegovy
Australian Public Assessment Report
Device/Product Name
Wegovy
Active ingredients
Semaglutide
AusPAR Date
Published
Submission Number
PM-2025-05799-1-2
Submission Type
New pharmaceutical dosage form (major variation)
Decision
Approved